The Clorox Company (NYSE:CLX) Receives Consensus Rating of “Reduce” from Brokerages

Shares of The Clorox Company (NYSE:CLX) have earned a consensus rating of “Reduce” from the fifteen research firms that are covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $155.00.

Several research analysts have recently commented on CLX shares. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and lifted their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Citigroup boosted their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. DA Davidson boosted their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Finally, Barclays upped their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st.

Clorox Trading Up 0.0 %

Shares of CLX stock opened at $164.68 on Friday. The stock’s fifty day moving average is $163.63 and its two-hundred day moving average is $151.21. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm has a market capitalization of $20.38 billion, a P/E ratio of 57.35, a PEG ratio of 3.08 and a beta of 0.42. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. Research analysts expect that Clorox will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is currently 170.03%.

Institutional Investors Weigh In On Clorox

Large investors have recently modified their holdings of the company. Inspire Trust Co. N.A. lifted its holdings in shares of Clorox by 5.9% during the third quarter. Inspire Trust Co. N.A. now owns 17,827 shares of the company’s stock worth $2,904,000 after purchasing an additional 1,000 shares during the period. Franklin Resources Inc. increased its position in shares of Clorox by 10.4% in the third quarter. Franklin Resources Inc. now owns 135,225 shares of the company’s stock valued at $21,840,000 after buying an additional 12,776 shares in the last quarter. Tidal Investments LLC increased its position in shares of Clorox by 1.3% in the third quarter. Tidal Investments LLC now owns 29,913 shares of the company’s stock valued at $4,873,000 after buying an additional 393 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its stake in shares of Clorox by 12.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 10,366 shares of the company’s stock valued at $1,689,000 after acquiring an additional 1,150 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its stake in shares of Clorox by 9.2% during the third quarter. Sanctuary Advisors LLC now owns 22,102 shares of the company’s stock valued at $3,742,000 after acquiring an additional 1,864 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.